DİKMEN, M. Et Al. 2019. Evaluation of the antileukemic effects of neurokinin-1 receptor antagonists, aprepitant, and L-733,060, in chronic and acute myeloid leukemic cells. ANTI-CANCER DRUGS , vol.30, no.7 , 693-705.

DİKMEN, M., Gokhaner, G., & CANTÜRK, Z., (2019). Evaluation of the antileukemic effects of neurokinin-1 receptor antagonists, aprepitant, and L-733,060, in chronic and acute myeloid leukemic cells. ANTI-CANCER DRUGS , vol.30, no.7, 693-705.

DİKMEN, MİRİŞ, Gokhan Gokhaner, And ZERRİN CANTÜRK. "Evaluation of the antileukemic effects of neurokinin-1 receptor antagonists, aprepitant, and L-733,060, in chronic and acute myeloid leukemic cells," ANTI-CANCER DRUGS , vol.30, no.7, 693-705, 2019

DİKMEN, MİRİŞ Et Al. "Evaluation of the antileukemic effects of neurokinin-1 receptor antagonists, aprepitant, and L-733,060, in chronic and acute myeloid leukemic cells." ANTI-CANCER DRUGS , vol.30, no.7, pp.693-705, 2019

DİKMEN, M. Gokhaner, G. And CANTÜRK, Z. (2019) . "Evaluation of the antileukemic effects of neurokinin-1 receptor antagonists, aprepitant, and L-733,060, in chronic and acute myeloid leukemic cells." ANTI-CANCER DRUGS , vol.30, no.7, pp.693-705.

@article{article, author={MİRİŞ DİKMEN Et Al. }, title={Evaluation of the antileukemic effects of neurokinin-1 receptor antagonists, aprepitant, and L-733,060, in chronic and acute myeloid leukemic cells}, journal={ANTI-CANCER DRUGS}, year=2019, pages={693-705} }